d-alpha tocopherol has been researched along with lovastatin in 29 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (3.45) | 18.7374 |
| 1990's | 11 (37.93) | 18.2507 |
| 2000's | 8 (27.59) | 29.6817 |
| 2010's | 9 (31.03) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Berra, A; Monserrat, AJ; Porta, EA; Rubio, MC | 1 |
| Bonal, J; Cantarell, C; Capdevila, L; Lauzurica, R; Pastor, C; Sierra, C | 1 |
| Anthony, M; Folkers, K; Loop, RA; Willis, RA | 1 |
| Brennan, GM; Bruce, I; Johnston, GD; McDowell, IF; McEneny, J; McVeigh, GE; Nicholls, DP; Trimble, ER; Young, IS | 1 |
| Clark, RW; Gordon, DA; Parker, RA; Pearce, BC; Wright, JJ | 1 |
| Guyton, JR; Hughes, H; Karsan, D; Lenz, ML; Mathews, B; Selinger, E; Smith, CV | 1 |
| Malminiemi, K; Metsä-Ketelä, T; Palomäki, A | 1 |
| Chen, L; Haught, WH; Mehta, JL; Parathasarathy, S; Saldeen, TG; Yang, B | 1 |
| Delport, R; Human, JA; Jerling, JJ; Lagendijk, J; Potgieter, HC; Ubbink, JB; Vermaak, WJ; Vorster, HH | 1 |
| Aslam, M; Kummerow, FA; Nangia, S; Onouchi, Z; Rastogi, SS; Singh, NK; Singh, RB; Wander, GS | 1 |
| Drukker, A; Eddy, AA | 1 |
| Malminiemi, K; Malminiemi, O; Palomäki, A; Solakivi, T | 1 |
| El-Swefy, S; El-Sweidy, M; Meydani, M; Ordovas, JM; Schaefer, EJ; Seman, LJ; Sevanian, A; Smith, DE; van Dongen, D | 1 |
| Bode-Böger, SM; Böger, RH; Brandes, RP; Brandes, S; Mügge, A | 1 |
| Kersting, F; Selenka, A; Walch, S | 1 |
| Malminiemi, K; Malminiemi, O; Palomäki, A | 1 |
| Peterson, DM; Qureshi, AA | 1 |
| Bok, SH; Choi, MS; Jang, MK; Jeon, SM; Lee, MK; Nam, KT; Park, YB; Rhee, SJ | 1 |
| Cole, WC; Kumar, B; Prasad, KN | 1 |
| Sylvester, PW; Wali, VB | 1 |
| Fernandes, NV; Guntipalli, PK; Mo, H | 1 |
| Dutta, D; Elfakhani, M; Fernandes, NV; Hynds, DL; Katuru, R; King, C; Mills, N; Mo, H | 1 |
| Fujino, H; Kawashima, T; Makiyama, T; Matsuzawa, Y; Murayama, T; Yamaura, E; Yamazaki, R | 1 |
| Abdul-Majeed, S; Mohamed, N; Soelaiman, IN | 1 |
| de Oliveira, CA; Guimarães, MR; Murad, LB; Paganelli, A; Vianna, LM | 1 |
| Chen, CC; Ho, CT; Huang, SP; Huang, TC; Liu, TY | 1 |
| Mo, H; Shen, CL; Torabi, S; Yeganehjoo, H | 1 |
1 review(s) available for d-alpha tocopherol and lovastatin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
6 trial(s) available for d-alpha tocopherol and lovastatin
| Article | Year |
|---|---|
Vitamin E in kidney transplantation: effect of treatment with simvastatin in hypercholesterolemia.
Topics: Anticholesteremic Agents; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Creatinine; Cyclosporine; Female; Follow-Up Studies; Humans; Hypercholesterolemia; Kidney Transplantation; Lovastatin; Male; Middle Aged; Simvastatin; Time Factors; Triglycerides; Vitamin E | 1995 |
The effect of probucol and vitamin E treatment on the oxidation of low-density lipoprotein and forearm vascular responses in humans.
Topics: Adult; Cholesterol, LDL; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Forearm; Humans; Hyperlipidemias; Hypolipidemic Agents; Lovastatin; Male; Middle Aged; Oxidation-Reduction; Probucol; Regional Blood Flow; Simvastatin; Vitamin E | 1994 |
Enhanced oxidizability of ubiquinol and alpha-tocopherol during lovastatin treatment.
Topics: Adult; Aged; Anticholesteremic Agents; Antioxidants; Apolipoproteins A; Apolipoproteins B; Cholesterol; Cholesterol, LDL; Copper; Coronary Disease; Cross-Over Studies; Double-Blind Method; Humans; Hypercholesterolemia; Lovastatin; Male; Middle Aged; Oxidation-Reduction; Triglycerides; Ubiquinone; Vitamin E | 1997 |
Effects of lovastatin therapy on susceptibility of LDL to oxidation during alpha-tocopherol supplementation.
Topics: Adult; Aged; Copper; Cross-Over Studies; Double-Blind Method; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipoproteins, LDL; Lovastatin; Male; Middle Aged; Oxidation-Reduction; Vitamin E | 1999 |
Effects of cholestyramine on vitamin E levels in patients treated with statins.
Topics: Adult; Aged; Anticholesteremic Agents; Antioxidants; Cholesterol, LDL; Cholestyramine Resin; Drug Interactions; Fatty Acids, Monounsaturated; Female; Fluvastatin; Humans; Indoles; Lovastatin; Male; Middle Aged; Naphthalenes; Pravastatin; Simvastatin; Vitamin E | 2000 |
Comparison of LDL trap assay to other tests of antioxidant capacity; effect of vitamin E and lovastatin treatment.
Topics: Amidines; Anticholesteremic Agents; Antioxidants; Copper Sulfate; Coronary Disease; Cross-Over Studies; Double-Blind Method; Humans; Hyperlipidemias; Lipoproteins, LDL; Lovastatin; Male; Oxidants; Oxidation-Reduction; Reproducibility of Results; Sensitivity and Specificity; Vitamin E | 2000 |
22 other study(ies) available for d-alpha tocopherol and lovastatin
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Effects of lovastatin and leupeptin on ceroidogenesis of vitamin E-deficient and -supplemented young rats.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Body Weight; Ceroid; Cholesterol; Dolichols; Eating; Female; Kidney; Leupeptins; Liver; Lovastatin; Organ Size; Rats; Rats, Inbred Strains; Vitamin E; Vitamin E Deficiency | 1989 |
Effects of ethanol, lovastatin and coenzyme Q10 treatment on antioxidants and TBA reactive material in liver of rats.
Topics: Animals; Antioxidants; Body Weight; Coenzymes; Diet; Diterpenes; Drug Evaluation, Preclinical; Ethanol; Liver; Liver Diseases, Alcoholic; Lovastatin; Organ Size; Oxidative Stress; Rats; Rats, Sprague-Dawley; Retinyl Esters; Thiobarbituric Acid Reactive Substances; Ubiquinone; Vitamin A; Vitamin E | 1994 |
Tocotrienols regulate cholesterol production in mammalian cells by post-transcriptional suppression of 3-hydroxy-3-methylglutaryl-coenzyme A reductase.
Topics: Acetates; Acetic Acid; Androstenes; Animals; Carbon Radioisotopes; Carcinoma, Hepatocellular; Cell Line; Chickens; CHO Cells; Cholesterol; Chromans; Cricetinae; Gene Expression Regulation, Enzymologic; Humans; Hydroxycholesterols; Hydroxymethylglutaryl CoA Reductases; Ketoconazole; Kinetics; Liver Neoplasms; Liver Neoplasms, Experimental; Lovastatin; Mevalonic Acid; Rats; RNA Processing, Post-Transcriptional; RNA, Messenger; Suppression, Genetic; Tritium; Tumor Cells, Cultured; Vitamin E | 1993 |
Toxicity of oxidized low density lipoproteins for vascular smooth muscle cells and partial protection by antioxidants.
Topics: Animals; Antioxidants; Aorta; Butylated Hydroxytoluene; Cell Death; Cells, Cultured; Copper; Culture Media; Deferoxamine; Enzyme Inhibitors; Hydroxycholesterols; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ketocholesterols; Lipid Peroxidation; Lipoproteins, LDL; Lovastatin; Mevalonic Acid; Muscle, Smooth, Vascular; Oxidation-Reduction; Probucol; Swine; Thiobarbituric Acid Reactive Substances; Vitamin E | 1995 |
Preservation of endogenous antioxidant activity and inhibition of lipid peroxidation as common mechanisms of antiatherosclerotic effects of vitamin E, lovastatin and amlodipine.
Topics: Amlodipine; Animals; Anticholesteremic Agents; Antioxidants; Arteriosclerosis; Calcium Channel Blockers; Diet, Atherogenic; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipid Peroxidation; Lovastatin; Rabbits; Superoxide Dismutase; Vitamin E | 1997 |
The effect of Simvastatin on the plasma antioxidant concentrations in patients with hypercholesterolaemia.
Topics: Adult; Anticholesteremic Agents; Antioxidants; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Coenzymes; Enzyme Inhibitors; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hyperlipoproteinemia Type II; Lipid Peroxidation; Lovastatin; Male; Middle Aged; Simvastatin; Ubiquinone; Vitamin E | 1997 |
Antioxidant effects of lovastatin and vitamin E on experimental atherosclerosis in rabbits.
Topics: Animals; Antioxidants; Aorta; Arteriosclerosis; Cholesterol; Coronary Vessels; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipid Peroxidation; Lovastatin; Rabbits; Single-Blind Method; Vitamin E | 1997 |
Failure of antioxidant therapy to attenuate interstitial disease in rats with reversible nephrotic syndrome.
Topics: Animals; Anticholesteremic Agents; Antioxidants; Cholesterol; Collagen; Female; Fibronectins; Fibrosis; Kidney; Lipid Peroxides; Lipoproteins, LDL; Liver; Lovastatin; Macrophages; Microscopy, Fluorescence; Nephrotic Syndrome; Organ Size; Probucol; Proteinuria; Puromycin Aminonucleoside; Rats; Rats, Sprague-Dawley; Time Factors; Transforming Growth Factor beta; Treatment Failure; Vitamin E | 1998 |
The effect of vitamin E, probucol, and lovastatin on oxidative status and aortic fatty lesions in hyperlipidemic-diabetic hamsters.
Topics: Animals; Animals, Newborn; Anticholesteremic Agents; Antioxidants; Arteriosclerosis; Cells, Cultured; Cricetinae; Diabetes Mellitus, Experimental; Disease Models, Animal; Foam Cells; Hyperlipidemias; Lipid Peroxidation; Lovastatin; Male; Mesocricetus; Probucol; Reference Values; Streptozocin; Vitamin E | 2000 |
L-arginine supplementation in hypercholesterolemic rabbits normalizes leukocyte adhesion to non-endothelial matrix.
Topics: Animals; Arginine; Cell Adhesion; Hypercholesterolemia; Leukocytes; Lovastatin; Male; Rabbits; Vitamin E | 2000 |
The combined effects of novel tocotrienols and lovastatin on lipid metabolism in chickens.
Topics: Animals; Anticholesteremic Agents; Chickens; Cholesterol; Cholesterol 7-alpha-Hydroxylase; Diet; Drug Synergism; Female; Hydroxymethylglutaryl CoA Reductases; Lipid Metabolism; Lipoproteins, LDL; Liver; Lovastatin; Vitamin E | 2001 |
Antioxidative activity of naringin and lovastatin in high cholesterol-fed rabbits.
Topics: Animals; Anticholesteremic Agents; Antioxidants; Body Weight; Catalase; Cholesterol, Dietary; Cytosol; Diet, Atherogenic; Flavanones; Flavonoids; Gene Expression Regulation, Enzymologic; Glutathione Peroxidase; Hydrogen Peroxide; Lipid Peroxidation; Lipid Peroxides; Liver; Lovastatin; Male; Mitochondria, Liver; Organ Size; Rabbits; RNA, Messenger; Superoxide Dismutase; Vitamin A; Vitamin E | 2001 |
Alpha tocopheryl succinate, retinoic acid and polar carotenoids enhanced the growth-inhibitory effect of a cholesterol-lowering drug on immortalized and transformed nerve cells in culture.
Topics: Animals; Anticholesteremic Agents; Antineoplastic Agents; Antioxidants; Carotenoids; Cell Line, Transformed; Cells, Cultured; Chromatography, High Pressure Liquid; Lovastatin; Mice; Neurons; Pravastatin; Rats; Tocopherols; Tretinoin; Vitamin E | 2001 |
Synergistic antiproliferative effects of gamma-tocotrienol and statin treatment on mammary tumor cells.
Topics: Animals; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Chromans; Dose-Response Relationship, Drug; Drug Synergism; Female; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Mammary Neoplasms, Animal; MAP Kinase Kinase 4; Mice; Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Pravastatin; Proto-Oncogene Proteins c-akt; Simvastatin; Vitamin E | 2007 |
d-δ-Tocotrienol-mediated cell cycle arrest and apoptosis in human melanoma cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Cycle; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Synergism; G1 Phase; Humans; Lovastatin; Melanoma, Experimental; Telophase; Vitamin E | 2010 |
Mevalonate depletion mediates the suppressive impact of geranylgeraniol on murine B16 melanoma cells.
Topics: 3T3-L1 Cells; Alkaline Phosphatase; Animals; Apoptosis; Cell Cycle; Cell Proliferation; Cyclin D1; Cyclin-Dependent Kinase 4; Diterpenes; Humans; Lovastatin; Melanoma, Experimental; Mevalonic Acid; Mice; Vitamin E | 2011 |
Inhibitory effects of clinical reagents having anti-oxidative activity on transforming growth factor-β1-induced expression of α-smooth muscle actin in human fetal lung fibroblasts.
Topics: Acetylcysteine; Actins; alpha-Tocopherol; Antioxidants; Cell Line; Fetus; Fibroblasts; Humans; Hypolipidemic Agents; Lovastatin; Lung; Phosphatidylcholines; Probucol; Reactive Oxygen Species; Superoxide Dismutase; Transforming Growth Factor beta1 | 2011 |
The use of delta-tocotrienol and lovastatin for anti-osteoporotic therapy.
Topics: Animals; Drug Synergism; Female; Femur; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Osteogenesis; Osteoporosis; Ovariectomy; Rats; Rats, Sprague-Dawley; Vitamin E | 2015 |
Effects of alpha-tocopherol associated with lovastatin on brain tissue and memory function in SHRSPs.
Topics: alpha-Tocopherol; Animals; Antioxidants; Body Weight; Brain; Cell Count; Disease Models, Animal; Drinking; Eating; Exploratory Behavior; L-Lactate Dehydrogenase; Lovastatin; Male; Malondialdehyde; Maze Learning; Memory Disorders; Rats; Rats, Inbred SHR; Stroke | 2015 |
Differentiation and apoptosis induction by lovastatin and γ-tocotrienol in HL-60 cells via Ras/ERK/NF-κB and Ras/Akt/NF-κB signaling dependent down-regulation of glyoxalase 1 and HMG-CoA reductase.
Topics: Active Transport, Cell Nucleus; Apoptosis; Cell Differentiation; Cell Line, Tumor; Cholesterol; Chromans; Down-Regulation; Extracellular Signal-Regulated MAP Kinases; HL-60 Cells; Humans; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lactoylglutathione Lyase; Lovastatin; Mevalonic Acid; NF-kappa B; Phosphorylation; Protein Transport; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins p21(ras); Pyruvaldehyde; raf Kinases; Signal Transduction; Vitamin E | 2015 |
Peroxisome proliferator-activated receptor γ down-regulation mediates the inhibitory effect of d-δ-tocotrienol on the differentiation of murine 3T3-F442A preadipocytes.
Topics: 3T3-L1 Cells; Adipocytes; Adipogenesis; Adipose Tissue; Animals; Cell Differentiation; Down-Regulation; Glucose; Glucose Transporter Type 4; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemic Agents; Lovastatin; Mevalonic Acid; Mice; PPAR gamma; Protein Serine-Threonine Kinases; Rosiglitazone; Thiazolidinediones; Triglycerides; Vitamin E | 2016 |